|
US5409959A
|
|
Antithrombotic treatment with calix(n)arene compounds
|
|
WO9220803A1
|
|
THE ASTROVIRUS HUMAN GASTROENTERITIS AGENTS AND MOLECULAR CLONING OF CORRESPONDING cDNAs
|
|
WO9216543A1
|
|
NORWALK VIRUS HUMAN GASTROENTERITIS AGENT AND MOLECULAR CLONING OF CORRESPONDING cDNAs
|
|
US5169753A
|
|
Method and kit for detecting human retrovirus
|
|
US5166056A
|
|
Recombinant trichosanthin and coding sequence
|
|
ZA9102581B
|
|
Hepatitis c virus epitopes
|
|
AU7765191A
|
|
Enterically transmitted non-A/non-B hepatitis viral agent and characteristic epitopes thereof
|
|
US5196452A
|
|
Macrocyclic anti-viral compound and method
|
|
US5166173A
|
|
Method of treating herpes simplex virus infection
|
|
AU5656890A
|
|
Chemically modified cd4 peptide fragments having anti-retroviral properties
|
|
US5128460A
|
|
Recombinant trichosanthin and coding sequence
|
|
CA2050593A1
|
|
Recombinant trichosanthin and coding sequence
|
|
AU5410290A
|
|
Purified trichosanthin and method of preparation
|
|
US5077390A
|
|
Purified trichosanthin and method of preparation
|
|
US5101025A
|
|
Recombinant trichosanthin and coding sequence
|
|
AU3974989A
|
|
Sequence-specific amplification techniques
|
|
EP0426756A1
|
|
Rna and dna amplification techniques
|
|
AU4046489A
|
|
Post-transfusion, non-a, non-b hepatitis virus and antigens
|
|
CN1044955A
|
|
Enterically transmitted non-A/non-B hepatitis viral agent
|
|
US5066579A
|
|
HTLV-I peptide antigen and assay
|
